Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody

Natural killer (NK) cells play a pivotal role in monoclonal antibody-mediated immunotherapy through the antibody-dependent cell-mediated cytotoxicity (ADCC) mechanism. NK-92MI is an interleukin-2 (IL-2)-independent cell line, which was derived from NK-92 cells with superior cytotoxicity toward a wid...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ying, You, Fengtao, Jiang, Licui, Li, Jialu, Zhu, Xuejun, Bao, Yangyi, Sun, Xiang, Tang, Xiaowen, Meng, Huimin, An, Gangli, Zhang, Bozhen, Yang, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514896/
https://www.ncbi.nlm.nih.gov/pubmed/28415754
http://dx.doi.org/10.18632/oncotarget.16201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514896/
https://www.ncbi.nlm.nih.gov/pubmed/28415754
http://dx.doi.org/10.18632/oncotarget.16201

Ejemplares similares